- Therapeutic genome editing of an aberrant splice site in β-thalassemia by CRISPR/Cas9 with multiple sgRNAsYang, Fei; Xu, Shuqian; Huang, Chao; Shao, Zhiqiang; Hu, Yuefen; Yang, Yang; Lai, Yongrong; Ke, Qing; Liang, Dan*; Wu, Yuxuan*Genes & Diseases, 2024, 11(1): 15-18.
- An Updated Follow-Up of BRL-101, CRISPR-Cas9-Mediated Gene Editing of the BCL11A Enhancer for Transfusion-Dependent β-thalassemiaFu, Bin; Zhang, Xinhua; Wang, Li; Liao, Jiaoyang; Chen, Shuanghong; Zheng, Biao; Li, Wei; Wang, Fei; Li, Dali; Liu, Mingyao; Wu, Yuxuan
- Therapeutic base editing of human hematopoietic stem cellsJing, Zeng; Yuxuan, Wu; Chunyan, Ren; Jasmine, Bonanno; Anne H., Shen; Devlin, Shea; Jason M., Gehrke; Kendell, Clement; Kevin, Luk; Qiuming, Yao; Rachel, Kim; Scot A., Wolfe; John P., Manis; Luca, Pinello; J. Keith, Joung; Daniel E., BauerNature Medicine, 2020, 26(4): 535-541.被引 35
会议论文
Prime Editing of the α-Thalassemia Hb Constant Spring Mutation
13阅读
